Literature DB >> 22213465

Synaptic vesicle recycling is enhanced by torsinA that harbors the DYT1 dystonia mutation.

Yasuhiro Kakazu1, Jin-Young Koh, K W David Ho, Pedro Gonzalez-Alegre, N Charles Harata.   

Abstract

Early-onset generalized dystonia, DYT1, is caused by a mutation in the gene encoding the evolutionarily conserved AAA+ ATPase torsinA. Synaptic abnormalities have been implicated in DYT1 dystonia, but the details of the synaptic pathophysiology are only partially understood. Here, we demonstrate a novel role for torsinA in synaptic vesicle recycling, using cultured hippocampal neurons from a knock-in mouse model of DYT1 dystonia (ΔE-torsinA) and live-cell imaging with styryl FM dyes. Neurons from heterozygous ΔE-torsinA mice released a larger fraction of the total recycling pool (TRP) during a single round of electrical stimulation than did wild-type neurons. Moreover, when the neurons were subjected to prior high activity, the time course of release was shortened. In neurons from homozygous mice, these enhanced exocytosis phenotypes were similar, but in addition the size of the TRP was reduced. Notably, when release was triggered by applying a calcium ionophore rather than electrical stimuli, neither a single nor two ΔE-torsinA alleles affected the time course of release. Thus, the site of action of ΔE-torsinA is at or upstream of the rise in calcium concentration in nerve terminals. Our results suggest that torsinA regulates synaptic vesicle recycling in central neurons. They also indicate that this regulation is influenced by neuronal activity, further supporting the idea that synaptic abnormalities contribute to the pathophysiology of DYT1 dystonia.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22213465     DOI: 10.1002/syn.21534

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  18 in total

Review 1.  Torsins: not your typical AAA+ ATPases.

Authors:  April E Rose; Rebecca S H Brown; Christian Schlieker
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-10-13       Impact factor: 8.250

Review 2.  Engineering animal models of dystonia.

Authors:  Janneth Oleas; Fumiaki Yokoi; Mark P DeAndrade; Antonio Pisani; Yuqing Li
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

3.  Structure of the Golgi apparatus is not influenced by a GAG deletion mutation in the dystonia-associated gene Tor1a.

Authors:  Sara B Mitchell; Sadahiro Iwabuchi; Hiroyuki Kawano; Tsun Ming Tom Yuen; Jin-Young Koh; K W David Ho; N Charles Harata
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

4.  Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia.

Authors:  Mark P DeAndrade; Amy Trongnetrpunya; Fumiaki Yokoi; Chad C Cheetham; Ning Peng; J Michael Wyss; Mingzhou Ding; Yuqing Li
Journal:  Mov Disord       Date:  2016-05-31       Impact factor: 10.338

Review 5.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

6.  Examination of synaptic vesicle recycling using FM dyes during evoked, spontaneous, and miniature synaptic activities.

Authors:  Sadahiro Iwabuchi; Yasuhiro Kakazu; Jin-Young Koh; Kirsty M Goodman; N Charles Harata
Journal:  J Vis Exp       Date:  2014-03-31       Impact factor: 1.355

7.  Rapid genotyping of animals followed by establishing primary cultures of brain neurons.

Authors:  Jin-Young Koh; Sadahiro Iwabuchi; Zhengmin Huang; N Charles Harata
Journal:  J Vis Exp       Date:  2015-01-29       Impact factor: 1.355

8.  Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.

Authors:  Mariangela Scarduzio; Chelsea N Zimmerman; Karen L Jaunarajs; Qin Wang; David G Standaert; Lori L McMahon
Journal:  Exp Neurol       Date:  2017-06-03       Impact factor: 5.330

Review 9.  In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder.

Authors:  Edna Grünblatt; Jasmin Bartl; Zoya Marinova; Susanne Walitza
Journal:  J Neural Transm (Vienna)       Date:  2012-07-26       Impact factor: 3.575

Review 10.  Emerging common molecular pathways for primary dystonia.

Authors:  Mark S Ledoux; William T Dauer; Thomas T Warner
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.